Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PepsiCo and Whole Foods

This article was originally published in The Tan Sheet

Executive Summary

PepsiCo has a new "high energy protein drink" called Fuelosophy. The milk-based product contains vitamins A, B, C, D and E and is being sold in test markets including some Whole Foods stores. The drink comes in four flavors: pomegranate berry, vanilla caramel, pineapple mango and citrus blend. It does not bear the PepsiCo logo or name...

You may also be interested in...



PepsiCo gets Naked

The soft-drink giant continues adding brands targeted for health-conscious consumers with the acquisition of Naked Juice Company, which says it has achieved annual sales of more than $150 mil. primarily through grassroots marketing and sales efforts. Azusa, Calif.-based Naked, which was controlled by North Castle Partners private equity firm, produces more than 25 juice and juice-smoothie Naked selections made from fruits and nutritional boosts and without sugars or preservatives. The deal, with terms not disclosed, comes the same month PepsiCo launched Fuelosophy, a milk-based product with vitamins A, B, C, D and E that is being sold in test markets including some Whole Foods stores (1"The Tan Sheet" Nov. 20, 2006, In Brief). PepsiCo says nearly all of Naked's beverages qualify for the "Smart Spot designation" it has made for its more than 250 "products that contribute to a healthier lifestyle."...

Are Regulators Ready For The Robot Era? ChatGPT Weighs In On EU Regulation

Artificial intelligence model’s comments signal the likely start of computer-generated comments to the US FDA’s public notices.

Pink Sheet Podcast: US FDA Loses Gene Therapy Expert, Humira Biosimilars Launch, FDA Allows In-Person Meetings

Pink Sheet reporters and editors consider the impact of FDA Office of Tissues and Advanced Therapies Director Wilson Bryan’s retirement, the launch of Humira biosimilars and its effect on the biologic market, as well as the FDA moving to hybrid meetings with sponsors.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099969

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel